Home » Topics » Conferences

Conferences
RSS

Endotis Pharma's synthetic oligosaccharide EP-80061 shows antitumor activity in animal models

May 4, 2010

GI-5005 plus pegIFNalpha-2a/RBV shows clinical potential in chronic HCV patients

May 4, 2010

Covalent irreversible HCV NS3 protease inhibitors disclosed by Avila Therapeutics

May 4, 2010

Phase I/II results reported for GMI-1070 in sickle cell disease

May 4, 2010

Four-year COMBAT data detail benefits of Duodart in benign prostatic hyperplasia

May 4, 2010

Palmitoylethanolamide enhances efficacy of topical ocular antihypertensive treatments

May 3, 2010

Phase III Trinity study results reported for olmesartan/amlodipine/HCTZ in hypertension

May 3, 2010

Cleveland Biolabs describes novel curaxin radiosensitizers for cancer

May 3, 2010

LigoCyte updates norovirus vaccine clinical development progress

May 3, 2010

Polo-like kinase 1 inhibitors from Cyclacel active in xenograft cancer models

May 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...